Back
Ionis Pharmaceuticals Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
39
IONS
Ionis Pharmaceuticals
Last Price:
$32.23
Seasonality Move:
-4.48%
Sell
31
APLS
Apellis Pharmaceuticals
Last Price:
$25.13
Seasonality Move:
2.12%
Sell
39
Ionis Pharmaceuticals (IONS)
is a Sell
Is Ionis Pharmaceuticals a Buy, Sell or Hold?
-
The current Ionis Pharmaceuticals [IONS] share price is $33.81. The Score for IONS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
IONS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $25.04. The Score for APLS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IONS Stock Price Chart
What is Ionis Pharmaceuticals's stock price today?
-
The Ionis Pharmaceuticals share price today is $33.81Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IONS is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $25.04Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight buying pressure.
IONS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 56.28 | Buy |
Chaikin Money Flow: | -1230081 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.26 - 33.22) | Buy |
Bollinger Bands (100): | (32.7 - 38.02) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.26 | Sell |
Relative Strength Index (14 RSI): | 35.99 | Sell |
Chaikin Money Flow: | 229447 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.81 - 29.35) | Sell |
Bollinger Bands (100): | (26.85 - 32.55) | Sell |
IONS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.97 | Buy |
20-day SMA: | 32.19 | Buy |
50-day SMA: | 33.25 | Buy |
200-day SMA: | 39.77 | Sell |
8-day EMA: | 33.22 | Buy |
20-day EMA: | 32.75 | Buy |
50-day EMA: | 33.5 | Buy |
200-day EMA: | 38.23 | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.37 | Sell |
20-day SMA: | 27.12 | Sell |
50-day SMA: | 29.39 | Sell |
200-day SMA: | 33.67 | Sell |
8-day EMA: | 25.63 | Sell |
20-day EMA: | 26.83 | Sell |
50-day EMA: | 28.63 | Sell |
200-day EMA: | 34.8 | Sell |
Ionis Pharmaceuticals Earnings Growth & IONS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and an increase next year of $0.57 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $1.09 per share.
Ionis Pharmaceuticals Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |